VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMW 2019 | MGUS pathology

Tarek H Mouhieddine, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the pathology and prognosis of monoclonal gammopathy of undetermined significance (MGUS) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter